-
1
المؤلفون: Vallejo-Vaz, AJ, Robertson, M, Catapano, AL, Watts, GF, Kastelein, JJ, Packard, CJ, Ford, I, Ray, KK
المساهمون: Sanofi Aventis
مصطلحات موضوعية: Male, Cardiac & Cardiovascular Systems, STATIN THERAPY, primary prevention, Hypercholesterolemia, Coronary Disease, ALL-CAUSE, 1117 Public Health and Health Services, lipids, Humans, FAMILIAL HYPERCHOLESTEROLEMIA, 1102 Cardiorespiratory Medicine and Haematology, METAANALYSIS, Pravastatin, CLINICAL EVENTS, RISK, Science & Technology, cardiovascular disease prevention, Anticholesteremic Agents, 1103 Clinical Sciences, Cholesterol, LDL, lipids and lipoproteins, Middle Aged, EFFICACY, cardiovascular diseases, lipoproteins, Peripheral Vascular Disease, Scotland, Cardiovascular System & Hematology, SAFETY, Cardiovascular System & Cardiology, lipids (amino acids, peptides, and proteins), LDL CHOLESTEROL, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Life Sciences & Biomedicine, Follow-Up Studies
URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1032::dee2514f70741d8a817b02b892bc1370
http://hdl.handle.net/10044/1/50367